Invacare (IVC) Announces Quarterly Earnings Results

Invacare (NYSE:IVC) announced its quarterly earnings data on Wednesday. The health services provider reported ($0.42) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.44) by $0.02, reports. Invacare had a negative return on equity of 13.33% and a negative net margin of 7.95%. The firm had revenue of $250.35 million for the quarter, compared to analysts’ expectations of $241.07 million. During the same quarter in the prior year, the firm posted ($0.46) earnings per share. Invacare’s revenue for the quarter was up 1.5% compared to the same quarter last year.

Shares of Invacare (NYSE IVC) traded up $1.80 during trading on Thursday, hitting $18.95. The stock had a trading volume of 1,118,402 shares, compared to its average volume of 407,068. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.28 and a quick ratio of 1.57. The firm has a market cap of $683.81, a PE ratio of -8.01 and a beta of 2.55. Invacare has a fifty-two week low of $9.90 and a fifty-two week high of $19.05.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, January 16th. Shareholders of record on Thursday, January 4th were paid a dividend of $0.0125 per share. This represents a $0.05 annualized dividend and a yield of 0.26%. The ex-dividend date of this dividend was Wednesday, January 3rd. Invacare’s payout ratio is currently -2.13%.

Several analysts have issued reports on the company. KeyCorp restated a “buy” rating and set a $18.00 price objective on shares of Invacare in a research note on Friday, November 10th. ValuEngine upgraded Invacare from a “sell” rating to a “hold” rating in a research note on Sunday, December 31st. Finally, Zacks Investment Research cut Invacare from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. Invacare presently has an average rating of “Hold” and an average target price of $16.00.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at

Invacare Company Profile

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Earnings History for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit